Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Equity Average (2018 - 2025)

Volitionrx filings provide 10 years of Equity Average readings, the most recent being -$35.8 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 50.46% to -$35.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$35.8 million, a 50.46% decrease, with the full-year FY2025 number at -$30.3 million, down 79.95% from a year prior.
  • Equity Average hit -$35.8 million in Q4 2025 for Volitionrx, down from -$34.5 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $28.9 million in Q2 2021 to a low of -$35.8 million in Q4 2025.
  • Median Equity Average over the past 5 years was -$1.6 million (2022), compared with a mean of -$4.6 million.
  • Biggest five-year swings in Equity Average: surged 107.52% in 2021 and later tumbled 3927.22% in 2023.
  • Volitionrx's Equity Average stood at $19.5 million in 2021, then crashed by 100.74% to -$143567.0 in 2022, then tumbled by 3927.22% to -$5.8 million in 2023, then crashed by 311.19% to -$23.8 million in 2024, then tumbled by 50.46% to -$35.8 million in 2025.
  • The last three reported values for Equity Average were -$35.8 million (Q4 2025), -$34.5 million (Q3 2025), and -$31.1 million (Q2 2025) per Business Quant data.